NEW YORK, Sept. 16, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Embraer S.A. securities (NYSE:ERJ) from April 16, 2012 through July 28, 2016, both dates inclusive (the “Class Period”) of the important October 7, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Embraer investors under the federal securities laws.
To join the Embraer class action, go to the firm’s website at http://rosenlegal.com/cases-929.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Embraer had paid bribes to officials in the Dominican Republic to secure contracts for the sale of aircraft; (2) Embraer’s President and Chief Executive Officer (“CEO”), Defendant Frederico Pinheiro Fleury Curado (“Curado”) was aware of the bribery scheme; (3) the foreseeable consequences of the bribery scheme would cost Embraer hundreds of millions of dollars; and (4) as a result, defendants’ statements about Embraer’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 7, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-929.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected]. Attorney Advertising. Prior results do not guarantee a similar outcome.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 



